Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'fosphenytoin' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dasgupta, A; Schlette, E
      Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: Role of alkaline phosphatase

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    2. Cheshire, WP
      Fosphenytoin: An intravenous option for the management of acute trigeminalneuralgia crisis

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    3. Pourrat, X; Serekian, JM; Antier, D; Grassin, J
      Generalized tonic-clonic status epilepticus: therapeutic strategy

      PRESSE MEDICALE
    4. Johnson, J; Wrenn, K
      Inappropriate fosphenytoin use in the ED

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    5. Aman, T; Firdous, S; Khan, IU; Kazi, AA
      Spectrophotometric determination of phenytoin sodium in pure and pharmaceutical preparations

      MIKROCHIMICA ACTA
    6. Burneo, JG; Anandan, JV; Barkley, GL
      A prospective study of the incidence of the purple glove syndrome

      EPILEPSIA
    7. Pryor, FM; Gidal, B; Ramsay, RE; DeToledo, J; Morgan, RO
      Fosphenytoin: Pharmacokinetics and tolerance of intramuscular loading doses

      EPILEPSIA
    8. Oellerich, M; Armstrong, VW
      Prodrug metabolites: Implications for therapeutic drug monitoring

      CLINICAL CHEMISTRY
    9. Jain, KK
      An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Anderson, GD; Lin, YX; Temkin, NR; Fischer, JH; Winn, HR
      Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin

      ANNALS OF PHARMACOTHERAPY
    11. Heafield, MTE
      Managing status epilepticus - New drug offers real advantages

      BRITISH MEDICAL JOURNAL
    12. Loscher, W; Reissmuller, E; Ebert, U
      Kindling alters the anticonvulsant efficacy of phenytoin in Wistar rats

      EPILEPSY RESEARCH
    13. Principe, A; Bouget, J
      Prodilantin: a new antiepileptic agent?

      PRESSE MEDICALE
    14. Presutti, M; Pollet, L; Stordeur, JM; Bruder, N; Gouin, F
      Phenytoin intoxication due to an error in the administration of fosphenytoin.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    15. Olson, SC; Bockbrader, H; Boyd, RA; Cook, J; Koup, JR; Lalonde, RL; Siedlik, PH; Powell, JR
      Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process - Experience at Parke-Davis

      CLINICAL PHARMACOKINETICS
    16. Bauer, J
      Current aspects of status epilepticus

      AKTUELLE NEUROLOGIE
    17. Appleton, R; Choonara, I; Martland, T; Phillips, B; Scott, R; Whitehouse, W
      The treatment of convulsive status epilepticus in children

      ARCHIVES OF DISEASE IN CHILDHOOD
    18. Dasgupta, A; Handy, BC; Datta, P
      Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase

      AJCP. American journal of clinical pathology
    19. Collins, M; Gidal, BE; Garnett, WRR; Reinfeldt, G; Tusch, GM
      Potential underreporting of intravenous phenytoin adverse events

      ANNALS OF PHARMACOTHERAPY
    20. Bosch, J; Roca, T; Domenech, J; Suriol, M
      Synthesis of water-soluble phenytoin prodrugs

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    21. Burstein, AH; Cox, DS; Mistry, B; Eddington, ND
      Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats

      EPILEPSY RESEARCH
    22. Aweeka, FT; Gottwald, MD; Gambertoglio, JG; Wright, TL; Boyer, TD; Pollock, AS; Eldon, MA; Kugler, AR; Alldredge, BK
      Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease

      EPILEPSIA
    23. Walton, NY; Uthman, BM; El Yafi, K; Kim, JM; Treiman, DM
      Phenytoin penetration into brain after administration of phenytoin or fosphenytoin

      EPILEPSIA
    24. Bleck, TP
      Management approaches to prolonged seizures and status epilepticus

      EPILEPSIA
    25. Scott, RC; Neville, BGR
      Pharmacological management of convulsive status epilepticus in children

      DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
    26. Meek, PD; Davis, SN; Collins, M; Gidal, BE; Rutecki, PA; Burstein, AH; Fischer, JH; Leppik, IE; Ramsay, RE
      Guidelines for nonemergency use of parenteral phenytoin products - Proceedings of an expert panel consensus process

      ARCHIVES OF INTERNAL MEDICINE
    27. Dasgupta, A; Warner, BF; Datta, P
      Use of alkaline phosphatase to correct the underestimation of fosphenytoinconcentration in serum measured by phenytoin immunoassays

      AJCP. American journal of clinical pathology
    28. Morton, LD; Pellock, JM
      Treatment options for acute seizure care - Use of new formulations

      CNS DRUGS
    29. Holliday, SM; Benfield, P; Plosker, GL
      Fosphenytoin - Pharmacoeconomic implications of therapy

      PHARMACOECONOMICS
    30. DASGUPTA A; HAVLIK D
      ELEVATED FREE FOSPHENYTOIN CONCENTRATIONS IN UREMIC SERA - UREMIC TOXINS HIPPURIC-ACID AND INDOXYL SULFATE DO NOT ACCOUNT FOR THE IMPAIRED PROTEIN-BINDING OF FOSPHENYTOIN

      Therapeutic drug monitoring
    31. LUER MS
      FOSPHENYTOIN

      Neurological research
    32. OBRIEN TJ; CASCINO GD; SO EL; HANNA DR
      INCIDENCE AND CLINICAL CONSEQUENCE OF THE PURPLE GLOVE SYNDROME IN PATIENTS RECEIVING INTRAVENOUS PHENYTOIN

      Neurology
    33. CHURCHILL JD; VOSS SE; MILLER DP; STEINMETZ JE; GARRAGHTY PE
      PHENYTOIN BLOCKS THE REVERSAL OF A CLASSICALLY-CONDITIONED DISCRIMINATIVE EYEBLINK RESPONSE IN RABBITS

      Epilepsia
    34. CHAN SA; REID KH; SCHURR A; MILLER JJ; IYER V; TSENG MT
      FOSPHENYTOIN REDUCES HIPPOCAMPAL NEURONAL DAMAGE IN RAT FOLLOWING TRANSIENT GLOBAL-ISCHEMIA

      Acta neurochirurgica
    35. CWIK MJ; LIANG MZ; DEYO K; ANDREWS C; FISCHER J
      SIMULTANEOUS RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PHENYTOIN AND ITS PRODRUG, FOSPHENYTOIN IN HUMAN PLASMA AND ULTRAFILTRATE

      Journal of chromatography B. Biomedical sciences and applications
    36. FISCHER JH; CWIK MJ; LUER MS; SIBLEY CB; DEYO KL
      STABILITY OF FOSPHENYTOIN SODIUM WITH INTRAVENOUS SOLUTIONS IN GLASS BOTTLES, POLYVINYL-CHLORIDE BAGS, AND POLYPROPYLENE SYRINGES

      The Annals of pharmacotherapy
    37. RAMSAY RE; WILDER BJ; UTHMAN BM; GARNETT WR; PELLOCK JM; BARKLEY GL; LEPPIK IE; KNAPP LE
      INTRAMUSCULAR FOSPHENYTOIN (CEREBYX(R)) IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN

      Epilepsy research
    38. BROWNE TR
      FOSPHENYTOIN (CEREBYX)

      Clinical neuropharmacology
    39. FIERRO LS; SAVULICH DH; BENEZRA DA
      SAFETY OF FOSPHENYTOIN SODIUM

      American journal of health-system pharmacy
    40. BRITTON JW; SO EL
      NEW ANTIEPILEPTIC DRUGS - PROSPECTS FOR THE FUTURE

      Journal of epilepsy
    41. TENHOOR CN; STEWART BH
      RECONVERSION OF FOSPHENYTOIN IN THE PRESENCE OF INTESTINAL ALKALINE-PHOSPHATASE

      Pharmaceutical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 06:47:17